Author

Geoffroy Bourquin

Idorsia Pharmaceuticals Ltd (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Mac SweeneyiD· 1 shared Daniel RitziD· 1 shared Julien HazemanniD· 1 shared Paul CzodrowskiiD· 1 shared Roland Lange· 1 shared Thierry Kimmerlin· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

A. Mac SweeneyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for de novo drug design and computational chemistry approaches

Julien Hazemann, Thierry Kimmerlin, Roland Lange, A. Mac Sweeney, Geoffroy Bourquin, Daniel Ritz, Paul Czodrowski

This study identifies novel SARS-CoV-2 Mpro inhibitors using deep reinforcement learning and computational chemistry methods, showing potent inhibitory activity with IC50 values between 1.3 and 2.3 uM.

RSC Medicinal Chemistry · Jan 1, 2024Peer-reviewedMolecular Biology